Colgate-Palmolive reported stable earnings for Q4 2024, beating EPS estimates but just missing revenue expectations.

Colgate-Palmolive Co. shares are down 4.9% Friday despite the toothpaste and toothbrush giant reporting better-than-expected ...

Strong earnings, soaring organic sales, and record-breaking margins--Colgate is winning, but currency headwinds loom.

Colgate-Palmolive reported a slight decline in Q4 sales, dropping 0.12% to $4.94 billion, missing estimates. However, organic ...

The headline numbers for Colgate-Palmolive (CL) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall ...

Morgan Stanley analyst Dara Mohsenian maintained a Buy rating on Colgate-Palmolive (CL – Research Report) today and set a price target of ...

Colgate-Palmolive (India) faces challenges from soft urban demand, stiff competitive, and margin pressures. While innovation ...

We recently published a list of 12 Best Defensive Stocks To Buy Right Now. In this article, we are going to take a look at where Colgate-Palmolive Company (NYSE:CL) stands against other best defensive ...

Ltd has reported a steady yet somewhat subdued financial performance for the third quarter and nine months ending 31 December 2024. In a world where Pepsodent, Sensodyne, and a slew of herbal ...

What is the outlook of the Colgate Palmolive stock price ahead of earnings? We explain whether it may drop soon ...

Colgate-Palmolive maintained its leadership position in oral care, with a 41.4% global market share in toothpaste and a 32.2% ...

Colgate-Palmolive (India) reports Q3 profit decline due to soft urban demand, focuses on driving growth through innovation.